Evidence map›Paper›PMID 17709553›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2007

Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.

Wassim M Ballan, Bien-Aimee N Vu, Brian R Long, Christopher P Loo, Jakob Michaëlsson, Jason D Barbour, Lewis L Lanier, Andrew A Wiznia, Jacobo Abadi, Glenn J Fennelly and 2 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. NK cells in treated HIV-infected children display altered phenotype and function.The Journal of allergy and clinical immunology · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. NKG2CFrontiers in immunology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Wassim M BallanDivision of Experimental Medicine, Department of Medicine, University of California-San Francisco, 1001 Potrero Avenue, San Francisco, CA 94110, USA. wassimballan@gmail.com
Bien-Aimee N Vu
Brian R Long
Christopher P Loo
Jakob Michaëlsson
Jason D Barbour
Lewis L Lanier
Andrew A Wiznia
Jacobo Abadi
Glenn J Fennelly
Michael G Rosenberg
Douglas F Nixon
University of California, San Francisco · USAlbert Einstein College of Medicine · USCancer Research Institute · USKarolinska Institutet · SESan Francisco General Hospital · US

Funding

NK Cells and HIV InfectionP01AI064520 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRODSKY, FRANCES M. · 2005 to 2009
$6.2M
Cell Mediated Immunity in HIV Infected ChildrenR01AI060379 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NIXON, DOUGLAS F · 2005 to 2009
$1.6M
Cell Mediated Immunity in HIV Infected ChildrenR21AI060379 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI NIXON, DOUGLAS F · 2004 to 2004
$374k
NIAID NIH HHS AI 060379NIAID NIH HHS AI 064520NIAID NIH HHS P01 AI064520NIAID NIH HHS R01 AI060379NIAID NIH HHS R21 AI060379
6 · The paper itself

Abstract

NK cells play an integral role in the innate immune response by targeting virally infected and transformed cells with direct killing and providing help to adaptive responses through cytokine secretion. Whereas recent studies have focused on NK cells in HIV-1-infected adults, the role of NK cells in perinatally HIV-1-infected children is less studied. Using multiparametric flow cytometric analysis, we assessed the number, phenotype, and function of NK cell subsets in the peripheral blood of perinatally HIV-1-infected children on highly active antiretroviral therapy and compared them to perinatally exposed but uninfected children. We observed an increased frequency of NK cells expressing inhibitory killer Ig-like receptors in infected children. This difference existed despite comparable levels of total NK cells and NK cell subpopulations between the two groups. Additionally, NK cell subsets from infected children expressed, with and without stimulation, significantly lower levels of the degranulation marker CD107, which correlates with NK cell cytotoxicity. Lastly, increased expression of KIR2DL3, NKG2C, and NKp46 on NK cells correlated with decreased CD4+ T-lymphocyte percentage, an indicator of disease severity in HIV-1- infected children. Taken together, these results show that HIV-1-infected children retain a large population of cytotoxically dysfunctional NK cells relative to perinatally exposed uninfected children. This reduced function appears concurrently with distinct NK cell surface receptor expression and is associated with a loss of CD4+ T cells. This finding suggests that NK cells may have an important role in HIV-1 disease pathogenesis in HIV-1-infected children.

Indexed as

HIV-1AdolescentCell DegranulationChildChild, PreschoolFemaleFlow CytometryHIV InfectionsHumansInfantKiller Cells, NaturalLymphocyte CountLysosomal-Associated Membrane Protein 1MaleNatural Cytotoxicity Triggering Receptor 1NK Cell Lectin-Like Receptor Subfamily CKIR2DL3 protein, humanKLRC2 protein, humanLysosomal-Associated Membrane Protein 1Natural Cytotoxicity Triggering Receptor 1NCR1 protein, humanNK Cell Lectin-Like Receptor Subfamily CReceptors, ImmunologicReceptors, KIR2DL3Receptors, Natural Killer Cell

Identifiers

PMID17709553
PMCPMC4271645
OpenAlexW2150123491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.